Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
基本信息
- 批准号:6777829
- 负责人:
- 金额:$ 24.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2009-03-30
- 项目状态:已结题
- 来源:
- 关键词:apoptosisbiological signal transductionbreast neoplasmscaloric dietary contentcancer preventioncarcinogenesiscell proliferationdietary lipiddietary restrictiondisease /disorder etiologydisease /disorder modelgene expressiongenetically modified animalsgrowth factor receptorshormone receptorinsulinlike growth factorlaboratory mouseleptinlongitudinal animal studymouse mammary tumor virusnutrition aspect of cancernutrition related tag
项目摘要
DESCRIPTION (provided by applicant): Many attempts have been made to identify dietary components that prevent development of breast cancer and/or mammary tumors (MTs). Few studies have produced conclusive findings. However, chronic caloric restriction consistently lowers MT incidence and extends latency in rodents. We find that intermittent restriction/refeeding prevents MT development in transgenic MMTV-TGF-a mice to a greater degree than does chronic restriction, i.e., 3% vs 44% incidence (vs 77% for ad libitum-fed mice). Thus, the manner in which calories are restricted has a major impact on MT development. Hypotheses: 1- The protective effect of intermittent restriction/refeeding is mediated by decreased serum IGF-I and leptin and effects on signaling pathways and/or proliferation/apoptosis; 2-The protective effect of intermittent restriction/refeeding is dependent upon periods of moderately severe caloric restriction and is modified by caloric intake and/or nutrient composition during refeeding; 3- The protective effects of chronic restriction and intermittent restriction/refeeding are dependent upon tumor etiology. In Specific Aim 1 the effect of intermittent restriction/refeeding and chronic restriction on serum IGF-I and leptin in longitudinal and cross-sectional protocols will be assessed. In Specific Aim 2 the effect of intermittent restriction/refeeding and chronic restriction on apoptosis, proliferation, and gene expression of IGF-I and leptin and their receptors in mammary tissue and MTs will be determined. In Specific Aim 3 the effect of serum leptin levels on the protective response of intermittent restriction/refeeding regimen on MT development will be determined. Specific Aim 4 will determine if the protective effect of intermittent caloric restriction/refeeding is dependent upon the MT oncogene and/or background strain of the transgenic mouse. Our long-term objectives are to establish nutrition intervention strategies applicable to humans and/or to provide insights leading to the development of chemopreventive agents to mimic this protective effect.
描述(由申请人提供):已经进行了许多尝试来确定预防乳腺癌和/或乳腺肿瘤(MT)发展的饮食成分。很少有研究得出结论性的结论。然而,长期热量限制会持续降低啮齿动物的 MT 发生率并延长潜伏期。我们发现,间歇性限制/再喂养比长期限制更大程度地阻止转基因 MMTV-TGF-a 小鼠的 MT 发育,即,发生率分别为 3% 和 44%(随意喂养的小鼠为 77%)。因此,限制热量的方式对 MT 的发展有重大影响。假设: 1- 间歇性限制/重新喂养的保护作用是由血清 IGF-I 和瘦素减少以及对信号通路和/或增殖/凋亡的影响介导的; 2-间歇性限制/重新喂养的保护作用取决于中度严重热量限制的时期,并根据重新喂养期间的热量摄入和/或营养成分而改变; 3- 长期限制和间歇性限制/再喂养的保护作用取决于肿瘤病因。在具体目标 1 中,将评估纵向和横向方案中间歇性限制/再喂养和长期限制对血清 IGF-I 和瘦素的影响。在具体目标 2 中,将确定间歇性限制/再喂养和长期限制对乳腺组织和 MT 中 IGF-I 和瘦素及其受体的细胞凋亡、增殖和基因表达的影响。在具体目标 3 中,将确定血清瘦素水平对间歇性限制/再喂养方案对 MT 发育的保护反应的影响。具体目标 4 将确定间歇性热量限制/再喂养的保护作用是否取决于转基因小鼠的 MT 癌基因和/或背景品系。我们的长期目标是建立适用于人类的营养干预策略和/或提供有助于开发化学预防剂以模仿这种保护作用的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margot P Cleary其他文献
Margot P Cleary的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margot P Cleary', 18)}}的其他基金
Prevention of mammary tumors by metformin in comparison to calorie restriction
与热量限制相比,二甲双胍预防乳腺肿瘤
- 批准号:
8110818 - 财政年份:2011
- 资助金额:
$ 24.6万 - 项目类别:
Prevention of mammary tumors by metformin in comparison to calorie restriction
与热量限制相比,二甲双胍预防乳腺肿瘤
- 批准号:
8706080 - 财政年份:2011
- 资助金额:
$ 24.6万 - 项目类别:
Prevention of mammary tumors by metformin in comparison to calorie restriction
与热量限制相比,二甲双胍预防乳腺肿瘤
- 批准号:
8509624 - 财政年份:2011
- 资助金额:
$ 24.6万 - 项目类别:
Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
- 批准号:
7046000 - 财政年份:2004
- 资助金额:
$ 24.6万 - 项目类别:
Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
- 批准号:
6878568 - 财政年份:2004
- 资助金额:
$ 24.6万 - 项目类别:
Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
- 批准号:
7368099 - 财政年份:2004
- 资助金额:
$ 24.6万 - 项目类别:
Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
- 批准号:
7217960 - 财政年份:2004
- 资助金额:
$ 24.6万 - 项目类别:
"FA" GENE, ADIPOCYTE LIPOGENESIS AND DIETARY FATTY ACIDS
“FA”基因、脂肪细胞脂肪生成和膳食脂肪酸
- 批准号:
3326406 - 财政年份:1989
- 资助金额:
$ 24.6万 - 项目类别:
"FA" GENE, ADIPOCYTE LIPOGENESIS AND DIETARY FATTY ACIDS
“FA”基因、脂肪细胞脂肪生成和膳食脂肪酸
- 批准号:
3326404 - 财政年份:1989
- 资助金额:
$ 24.6万 - 项目类别:
"FA" GENE, ADIPOCYTE LIPOGENESIS AND DIETARY FATTY ACIDS
“FA”基因、脂肪细胞脂肪生成和膳食脂肪酸
- 批准号:
3326405 - 财政年份:1989
- 资助金额:
$ 24.6万 - 项目类别:
相似国自然基金
硫化氢抑制采后枸杞乙烯生物合成及其信号转导的机理研究
- 批准号:32360612
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
基于“丛枝菌根真菌-激素信号转导-转录因子-L/ODC基因”调控路径解析苦参生物碱生物合成的调控机制
- 批准号:82304678
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生物钟核心转录因子PRRs调控JA信号转导及植物对灰霉菌防御的分子机理
- 批准号:32370606
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CmMYB整合生长素及乙烯信号转导因子调控菊花花青素苷生物合成的分子机制及网络解析
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
新型信号转导光电化学免疫生物传感对肝癌相关分子标志物检测新方法研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
以前列腺癌为模型的强化降胆固醇干预和抗肿瘤免疫
- 批准号:
10802975 - 财政年份:2023
- 资助金额:
$ 24.6万 - 项目类别:
A novel breast cancer therapy based on secreted protein ligands from CD36+ fibroblasts
基于 CD36 成纤维细胞分泌蛋白配体的新型乳腺癌疗法
- 批准号:
10635290 - 财政年份:2023
- 资助金额:
$ 24.6万 - 项目类别:
HER1-3 and Death Receptor protein folding as therapeutic vulnerabilities
HER1-3 和死亡受体蛋白折叠作为治疗漏洞
- 批准号:
10721930 - 财政年份:2023
- 资助金额:
$ 24.6万 - 项目类别:
Characterization of novel pyrazole compounds with potent anti-cancer activity
具有有效抗癌活性的新型吡唑化合物的表征
- 批准号:
10627543 - 财政年份:2023
- 资助金额:
$ 24.6万 - 项目类别: